OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Successful Treatment of Persistent Symptomatic Coronavirus Disease 19 Infection With Extended-Duration Nirmatrelvir-Ritonavir Among Outpatients With Hematologic Cancer
Catherine Liu, Leah H Yoke, Pooja Bhattacharyya, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 6
Open Access | Times Cited: 10
Catherine Liu, Leah H Yoke, Pooja Bhattacharyya, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 6
Open Access | Times Cited: 10
Showing 10 citing articles:
Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma
Taketomo Maruki, Hidetoshi Nomoto, Noriko Iwamoto, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 8, pp. 793-795
Closed Access | Times Cited: 4
Taketomo Maruki, Hidetoshi Nomoto, Noriko Iwamoto, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 8, pp. 793-795
Closed Access | Times Cited: 4
COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics
Emily A. Rosen, Elizabeth M. Krantz, Denise J. McCulloch, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 11, pp. 1108.e1-1108.e11
Closed Access | Times Cited: 4
Emily A. Rosen, Elizabeth M. Krantz, Denise J. McCulloch, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 11, pp. 1108.e1-1108.e11
Closed Access | Times Cited: 4
Effectiveness of nirmatrelvir/ritonavir in hospitalized haematological malignancy patients with mild‐to‐moderate COVID ‐19: A retrospective study
Hongbin Yu, Tian Chen, Jiawei Li, et al.
British Journal of Haematology (2025)
Open Access
Hongbin Yu, Tian Chen, Jiawei Li, et al.
British Journal of Haematology (2025)
Open Access
ORCHESTRA Delphi Consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients
Lorenzo Maria Canziani, Anna Maria Azzini, Jon Salmanton‐García, et al.
Clinical Microbiology and Infection (2025)
Closed Access
Lorenzo Maria Canziani, Anna Maria Azzini, Jon Salmanton‐García, et al.
Clinical Microbiology and Infection (2025)
Closed Access
Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID‐19 infection at an ambulatory cancer center
Eduardo Sanchez, Elizabeth M. Krantz, Leah M. Yoke, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 3
Eduardo Sanchez, Elizabeth M. Krantz, Leah M. Yoke, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 3
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
Paul Kinsella, Michael A. Moso, C. Orla Morrissey, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 3
Paul Kinsella, Michael A. Moso, C. Orla Morrissey, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 3
Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions
Abby E. Rudolph, Farid Khan, Tanya Singh, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 9, pp. 2035-2052
Open Access | Times Cited: 2
Abby E. Rudolph, Farid Khan, Tanya Singh, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 9, pp. 2035-2052
Open Access | Times Cited: 2
Treatment of Persistent Coronavirus Disease 2019 (COVID-19) in a B Cell Acute Lymphoblastic Leukemia Patient with Using Nirmatrelvir/Ritonavir Extended Course: A Case Report
Hassan Almarhabi, Aisha Alharbi, Mai Alalawi, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 10, pp. 102526-102526
Open Access | Times Cited: 1
Hassan Almarhabi, Aisha Alharbi, Mai Alalawi, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 10, pp. 102526-102526
Open Access | Times Cited: 1
Successful dual antiviral therapy with remdesivir and ensitrelvir in a case of prolonged COVID-19 following B-cell depleting immunotherapy for malignant lymphoma
Seowoong Jung, Yu Yagi, Kazuaki Fukushima, et al.
IDCases (2023) Vol. 34, pp. e01890-e01890
Open Access | Times Cited: 2
Seowoong Jung, Yu Yagi, Kazuaki Fukushima, et al.
IDCases (2023) Vol. 34, pp. e01890-e01890
Open Access | Times Cited: 2
Successful Sequential Treatment From Remdesivir to Molnupiravir for Prolonged COVID-19 in a Patient With Follicular Lymphoma and Renal Pelvic Carcinoma: A Case Report
Takahiro Sato, Kentaro Akata, Kei Yamasaki, et al.
Cureus (2024)
Open Access
Takahiro Sato, Kentaro Akata, Kei Yamasaki, et al.
Cureus (2024)
Open Access
